Editor of Patient Care Online.
FDA Advisory Committee Narrowly Backs Merck’s Oral COVID-19 Antiviral
The 13-10 vote was not without controversy as panel members discussed concerns over the novel antiviral's safety risks and modest efficacy.
COVID-19 Booster Shot Report Card: 10 Highest-ranked States
Find out which states have the most fully vaccinated persons who have received a COVID-19 booster dose in this quick slideshow.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 30, 2021
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 23, 2021
Primary Viewpoints Episode 12: Weight Stigma and Bias in Health Care
In our latest podcast episode, an obesity expert talks weight bias in health care, its widespread impact, and the advocacy work that is being done to change the narrative.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 22, 2021
FDA, CDC Authorize Use of Pfizer, Moderna Booster Shots for Every US Adult
Booster doses for US adults at least 18 years of age are expected to be available as soon as this weekend.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 19, 2021
Oral PCSK9 Inhibitor Significantly Reduced High Levels of Cholesterol in Phase 1 Trials
AHA 2021: New research showed MK-0616, an investigative oral PCSK9 inhibitor, was associated with a near 65% decrease in LDL-C.
COVID-19 Misinformation Still Rampant in US: Kaiser Family Foundation Findings
New survey finds 78% of US adults either believe or are unsure about at least 4 of 8 COVID-19 myths tested, with unvaccinated adults among the most likely to hold misconceptions.
Study: One-fifth of Patients with Cirrhosis Prescribed Opioids During Clinic Visits
In a new study of patients with cirrhosis, over two-thirds of outpatient clinic visits that included an opioid prescription were with primary care physicians.
Remote Program Improves Blood Pressure and Cholesterol in High-risk Patients
AHA 2021: Study suggests remote hypertension and hyperlipidemia management programs may expand telehealth delivery, increase access to care, and reduce health inequities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 15, 2021
AHA 2021: Novel Fitbit Algorithm Correctly Detected Undiagnosed Atrial Fibrillation
AHA 2021: Novel software algorithm used in Fitbit wearable devices accurately detected undiagnosed atrial fibrillation about 98% of the time, showed results of the Fitbit Heart Study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 12, 2021
Population for Digital Heart Failure Coaching App May Need Rethinking
AHA Scientific Sessions 2021: New research provides a note of caution for the use of digital heart failure coaching apps in severely ill and elderly patients with unstable heart failure.
Study Highlights Factors that Influence Patient Engagement with Remote CVD Risk Reduction Intervention
AHA Scientific Sessions 2021: Employment status and higher caregiver burden were linked to increased engagement with a videoconferencing-based intervention to reduce the risk of CVD.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 10, 2021
Living in More Socially Vulnerable Neighborhood Linked to Worse Outcomes in Hospitalized COVID-19 Patients
AHA Scientific Sessions 2021: New research found living in socially vulnerable neighborhoods increased the risk of myocardial infarction, stroke, or death among hospitalized COVID-19 patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 9, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 8, 2021
Young Black Adults Experienced Rising Burden of CVD Risk Factors, Worse Hospital Outcomes in 10-year Study
AHA Scientific Sessions 2021: National study of over 2.9 million young Black adults showed increased rates of CVD risk factors and worsened hospital outcomes between 2007 and 2017.
Semaglutide Demonstrates Significant Weight Loss, Improved Cardiometabolic Profile in Adults with Moderate-to-Severe Obesity
Semaglutide 2.4 mg led to clinically significant weight loss and improvements in cardiometabolic risk factors in adults with moderate or severe obesity, suggests new research from ObesityWeek 2021.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 4, 2021
CDC Signs Off on Pfizer’s COVID-19 Vaccine for Children Aged 5-11 Years
CDC Director Rochelle Walensky officially endorsed Pfizer's COVID-19 vaccine in children aged 5 to 11 years, following recommendation from ACIP.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of November 2, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Pragmatic Execution of Online Obesity Treatment in Primary Care Found Effective in New Study
ObesityWeek 2021: Regular engagement in online behavioral obesity treatment program within primary care network produced clinically significant weight loss in new study.
Study: Medical Weight Management May Prevent Pandemic-induced Weight Gain
ObesityWeek 2021: New study highlights protective effects of medical weight management during COVID-19 pandemic.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of November 1, 2021
Global confirmed deaths due to COVID-19 have surpassed 5 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map and the CDC.